• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒感染患者中堪萨斯分枝杆菌和结核分枝杆菌所致疾病的流行病学、临床及预后差异:一项多中心研究

Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study.

作者信息

Canueto-Quintero Jesús, Caballero-Granado Francisco Javier, Herrero-Romero Marta, Domínguez-Castellano Angel, Martín-Rico Patricia, Verdú Elisa Vidal, Santamaría Daniel Selma, Cerquera Ricardo Creagh, Torres-Tortosa Manuel

机构信息

Infectious Diseases Section, Punta de Europa Hospital, Algeciras, Spain.

出版信息

Clin Infect Dis. 2003 Aug 15;37(4):584-90. doi: 10.1086/376987. Epub 2003 Aug 1.

DOI:10.1086/376987
PMID:12905144
Abstract

A multicenter, comparative study was performed to determine the epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium tuberculosis and Mycobacterium kansasii in human immunodeficiency virus (HIV)-infected patients. From 1 January 1995 through 31 December 1999, 25 HIV-infected patients received diagnoses of M. kansasii infection, and another 75 were selected as control subjects from among patients who had M. tuberculosis infection. Variables associated with M. tuberculosis disease in the multivariate analysis were previous intravenous drug use (odds ratio [OR], 8; 95% confidence interval [CI], 1.5-41.4) and interstitial radiologic pattern (OR, 12.7; 95% CI, 1.7-94.3). Variables associated with M. kansasii were previous diagnosis of acquired immunodeficiency syndrome (OR, 15.8; 95% CI, 4.2-59.6) and concomitant opportunistic infections (OR, 14.2; 95% CI, 2-105.7). Clinical and radiologic features were similar for both groups, but epidemiological characteristics and prognosis were different. M. kansasii disease was associated more closely with level of immunosuppression and progression of HIV infection than was disease caused by M. tuberculosis.

摘要

开展了一项多中心比较研究,以确定人类免疫缺陷病毒(HIV)感染患者中结核分枝杆菌和堪萨斯分枝杆菌所致疾病在流行病学、临床及预后方面的差异。1995年1月1日至1999年12月31日期间,25例HIV感染患者被诊断为堪萨斯分枝杆菌感染,另外75例从结核分枝杆菌感染患者中选为对照。多变量分析中与结核分枝杆菌病相关的变量为既往静脉吸毒史(比值比[OR],8;95%置信区间[CI],1.5 - 41.4)和间质放射学表现(OR,12.7;95% CI,1.7 - 94.3)。与堪萨斯分枝杆菌相关的变量为既往获得性免疫缺陷综合征诊断(OR,15.8;95% CI,4.2 - 59.6)和合并机会性感染(OR,14.2;95% CI,2 - 105.7)。两组的临床和放射学特征相似,但流行病学特征和预后不同。与结核分枝杆菌所致疾病相比,堪萨斯分枝杆菌病与免疫抑制水平及HIV感染进展的关联更为密切。

相似文献

1
Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study.人类免疫缺陷病毒感染患者中堪萨斯分枝杆菌和结核分枝杆菌所致疾病的流行病学、临床及预后差异:一项多中心研究
Clin Infect Dis. 2003 Aug 15;37(4):584-90. doi: 10.1086/376987. Epub 2003 Aug 1.
2
[Disease caused by Mycobacterium kansasii in patients with HIV infection].
Enferm Infecc Microbiol Clin. 1993 Mar;11(3):120-5.
3
[Infections with Mycobacterium kansasii in the Academic Medical Center in Amsterdam: the changing clinical spectrum since the start of the HIV epidemic].[阿姆斯特丹学术医学中心的堪萨斯分枝杆菌感染:自艾滋病流行开始以来不断变化的临床谱]
Ned Tijdschr Geneeskd. 1998 Apr 25;142(17):965-9.
4
Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy.1型人类免疫缺陷病毒感染患者中的堪萨斯分枝杆菌病:高效抗逆转录病毒治疗时代预后改善
Int J Tuberc Lung Dis. 2003 Jul;7(7):673-7.
5
[Pulmonary infection by Mycobacterium kansasii. Presentation of 27 cases (1988-1992)].堪萨斯分枝杆菌引起的肺部感染。27例病例报告(1988 - 1992年)
Enferm Infecc Microbiol Clin. 1994 Jun-Jul;12(6):280-4.
6
Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection.感染和未感染人类免疫缺陷病毒患者的结核分枝杆菌菌血症
Arch Intern Med. 1993 Feb 22;153(4):496-500.
7
Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison.入狱时静脉吸毒者中结核分枝杆菌与人类免疫缺陷病毒合并感染情况
Int J Tuberc Lung Dis. 2000 Jan;4(1):41-6.
8
Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.堪萨斯分枝杆菌肺部感染与人类免疫缺陷病毒的死亡率预测
Am J Respir Crit Care Med. 2004 Oct 1;170(7):793-8. doi: 10.1164/rccm.200402-162OC. Epub 2004 Jun 23.
9
Mycobacterial bacteraemia in patients infected and not infected with human immunodeficiency virus, Taiwan.台湾人类免疫缺陷病毒感染者和未感染者中的分枝杆菌菌血症。
Clin Microbiol Infect. 2010 Jun;16(6):627-30. doi: 10.1111/j.1469-0691.2009.02939.x. Epub 2009 Aug 26.
10
Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.1997年至2000年在纽约市接受基于利福平或利福布汀治疗方案的HIV感染结核病患者的复发及获得性利福平耐药情况。
Clin Infect Dis. 2005 Jul 1;41(1):83-91. doi: 10.1086/430377. Epub 2005 May 26.

引用本文的文献

1
Cutaneous Manifestations of Infection.感染的皮肤表现
Curr Trop Med Rep. 2018 Dec;5(4):224-227. doi: 10.1007/s40475-018-0160-8. Epub 2018 Aug 6.
2
Drug susceptibility profiling of pulmonary and its correlation with treatment outcome.肺部药物敏感性分析及其与治疗结果的相关性。
Ann Thorac Med. 2021 Oct-Dec;16(4):323-328. doi: 10.4103/atm.atm_45_21. Epub 2021 Oct 26.
3
Mycobacterial Evolution Intersects With Host Tolerance.分枝杆菌进化与宿主耐受相交织。
Front Immunol. 2019 Mar 22;10:528. doi: 10.3389/fimmu.2019.00528. eCollection 2019.
4
Therapy for Infection: Beyond 2018.感染治疗:2018年之后
Front Microbiol. 2018 Sep 24;9:2271. doi: 10.3389/fmicb.2018.02271. eCollection 2018.
5
Mycobacterium kansasii.堪萨斯分枝杆菌。
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0011-2016.
6
Isolated wound infection and Osteomyelitis in an immunocompetent patient.免疫功能正常患者的孤立性伤口感染和骨髓炎。
Oxf Med Case Reports. 2016 Nov 4;2016(11):omw087. doi: 10.1093/omcr/omw087. eCollection 2016 Nov.
7
Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii.通过堪萨斯分枝杆菌分析对结核分枝杆菌出现的见解。
Genome Biol Evol. 2015 Feb 25;7(3):856-70. doi: 10.1093/gbe/evv035.
8
Other HIV-associated pneumonias.其他与 HIV 相关的肺炎。
Clin Chest Med. 2013 Jun;34(2):243-54. doi: 10.1016/j.ccm.2013.01.007. Epub 2013 Apr 8.
9
Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.利奈唑胺、泰利霉素、克拉霉素、左氧氟沙星、莫西沙星及四种传统抗分枝杆菌药物对堪萨斯分枝杆菌的体外活性比较
Antimicrob Agents Chemother. 2004 Dec;48(12):4562-5. doi: 10.1128/AAC.48.12.4562-4565.2004.